Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 35Pancreatic Fistula 4Pancreatic Ductal Adenocarcinoma 2Bile Duct Neoplasms 2Recurrence 1Peritoneal Diseases 1Periampullary Cancer 1Pancreatitis, Chronic 1Pancreatic Adenocarcinoma 1Obesity 1Neoplasm Metastasis 1Metabolic Syndrome 1Locally Advanced Pancreatic Adenocarcinoma 1Jaundice, Obstructive 1Hypoxia 1Hemorrhage 1Gastrointestinal Stromal Tumor of Duodenum 1Diabetes Mellitus 1Cholangiocarcinoma 1Carcinoma, Pancreatic Ductal 1Adenocarcinoma 1

Interventions

Oxaliplatin 10Gemcitabine 8Cisplatin 7Hepatectomy 6Fluorouracil 6Radiofrequency Ablation 5Liver Transplantation 5Irinotecan 5Capecitabine 5lenvatinib 4Paclitaxel 4Neoadjuvant Therapy 4Folfox protocol 4Cetuximab 4Aspirin 4tislelizumab 3Surgical Procedures, Operative 3Nivolumab 3Carboplatin 3titanium silicide 2durvalumab 2apatinib 2Trastuzumab 2S 1 (combination) 2Leucovorin 2Lamivudine 2Introns 2Ethiodized Oil 2Drug Therapy 2DNA, Mitochondrial 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recurrence × Pancreaticoduodenectomy × Gastrointestinal × Clear all
NCT04596865 2023-11-18

Recurrence After Whipple's (RAW) Study

University Hospital Plymouth NHS Trust

Completed
1,484 enrolled
Gastrointestinal

Bile Duct Neoplasms, Pancreatic Neoplasms, Recurrence, Cholangiocarcinoma, Carcinoma, Pancreatic Ductal

Data powered by HemOnc (CC BY 4.0) Colophon âš¡